For help on how to get the results you want, see our search tips.
1548 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Aimovig (updated)
erenumab, Migraine Disorders
Date of authorisation: 26/07/2018,
, Revision: 6, Authorised, Last updated: 15/06/2021
-
List item
Human medicine European public assessment report (EPAR): Efmody (updated)
hydrocortisone, Adrenal Hyperplasia, Congenital
Date of authorisation: 27/05/2021, Authorised, Last updated: 14/06/2021 -
List item
Human medicine European public assessment report (EPAR): Neparvis (updated)
sacubitril, valsartan, Heart Failure
Date of authorisation: 26/05/2016,, Revision: 12, Authorised, Last updated: 11/06/2021
-
List item
Human medicine European public assessment report (EPAR): Entresto (updated)
sacubitril, valsartan, Heart Failure
Date of authorisation: 19/11/2015, Revision: 13, Authorised, Last updated: 11/06/2021 -
List item
Human medicine European public assessment report (EPAR): Skyrizi (updated)
Risankizumab, Psoriasis
Date of authorisation: 26/04/2019,, Revision: 5, Authorised, Last updated: 11/06/2021
-
List item
Human medicine European public assessment report (EPAR): Zejula (updated)
Niraparib (tosilate monohydrate), Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms
Date of authorisation: 16/11/2017,, 
, Revision: 13, Authorised, Last updated: 11/06/2021
-
List item
Human medicine European public assessment report (EPAR): DaTSCAN (updated)
ioflupane (123l), Tomography, Emission-Computed, Single-Photon, Lewy Body Disease, Parkinson Disease, Alzheimer Disease
Date of authorisation: 27/07/2000, Revision: 23, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): Xerava (updated)
eravacycline, Infection, Bacterial Infections
Date of authorisation: 20/09/2018,, Revision: 2, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm (updated)
clopidogrel (as hydrogen sulfate), Myocardial Infarction, Acute Coronary Syndrome, Peripheral Vascular Diseases, Stroke
Date of authorisation: 18/02/2015,
, Revision: 11, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Targretin (updated)
bexarotene, Lymphoma, T-Cell, Cutaneous
Date of authorisation: 29/03/2001, Revision: 22, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): Cometriq (updated)
cabozantinib, Thyroid Neoplasms
Date of authorisation: 21/03/2014,, , 
, Revision: 22, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Zalasta (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 27/09/2007,, Revision: 18, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Erelzi (updated)
etanercept, Arthritis, Psoriatic, Psoriasis, Arthritis, Juvenile Rheumatoid, Arthritis, Rheumatoid, Spondylitis, Ankylosing
Date of authorisation: 23/06/2017,, 
, Revision: 9, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)
clopidogrel (as hydrogen sulfate), Acute Coronary Syndrome, Peripheral Vascular Diseases, Myocardial Infarction, Stroke
Date of authorisation: 27/07/2009,, Revision: 17, Authorised, Last updated: 10/06/2021
-
List item
Human medicine European public assessment report (EPAR): Qtern (updated)
Saxagliptin, dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2
Date of authorisation: 15/07/2016, Revision: 7, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): Saxenda (updated)
liraglutide, Obesity, Overweight
Date of authorisation: 23/03/2015, Revision: 10, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): Odefsey (updated)
emtricitabine, rilpivirine hydrochloride, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/06/2016, Revision: 18, Authorised, Last updated: 10/06/2021 -
List item
Human medicine European public assessment report (EPAR): DuoResp Spiromax (updated)
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 28/04/2014, Revision: 11, Authorised, Last updated: 09/06/2021 -
List item
Human medicine European public assessment report (EPAR): BiResp Spiromax (updated)
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 28/04/2014, Revision: 11, Authorised, Last updated: 09/06/2021 -
List item
Human medicine European public assessment report (EPAR): Benlysta (updated)
belimumab, Lupus Erythematosus, Systemic
Date of authorisation: 13/07/2011,, Revision: 26, Authorised, Last updated: 09/06/2021
-
List item
Human medicine European public assessment report (EPAR): Zoely (updated)
Nomegestrol acetate, estradiol, Contraception
Date of authorisation: 26/07/2011,, Revision: 20, Authorised, Last updated: 09/06/2021
-
List item
Human medicine European public assessment report (EPAR): Carbaglu (updated)
carglumic acid, Amino Acid Metabolism, Inborn Errors, Propionic Acidemia
Date of authorisation: 24/01/2003, Revision: 18, Authorised, Last updated: 09/06/2021 -
List item
Human medicine European public assessment report (EPAR): Hulio (updated)
adalimumab, Hidradenitis Suppurativa, Psoriasis, Crohn Disease, Uveitis, Arthritis, Rheumatoid, Colitis, Ulcerative, Spondylitis, Ankylosing, Arthritis, Psoriatic
Date of authorisation: 17/09/2018,, , Revision: 6, Authorised, Last updated: 09/06/2021
-
List item
Human medicine European public assessment report (EPAR): Talzenna (updated)
talazoparib, Breast Neoplasms
Date of authorisation: 20/06/2019,, Revision: 4, Authorised, Last updated: 09/06/2021
-
List item
Human medicine European public assessment report (EPAR): Voriconazole Hikma (previously Voriconazole Hospira) (updated)
voriconazole, Bacterial Infections and Mycoses, Aspergillosis, Candidiasis
Date of authorisation: 27/05/2015,, Revision: 9, Authorised, Last updated: 09/06/2021